Novel solid forms of oxaprozin: cocrystals and an extended release drug–drug salt of salbutamol
Author:
Affiliation:
1. Crystallization and Particle Science
2. Institute of Chemical and Engineering Sciences
3. A*STAR (Agency for Science, Technology and Research)
4. Singapore
5. Department of Chemical & Biomolecular Engineering
Abstract
Novel solid forms of an anti-inflammatory drug, oxaprozin, were identified. A drug–drug salt of oxaprozin with salbutamol was proved promising for development of extended release tablet formulations of salbutamol.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA01802E
Reference41 articles.
1. The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs
2. Comparative study of oxaprozin complexation with natural and chemically-modified cyclodextrins in solution and in the solid state
3. Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components
4. Accessed the data from http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bifonazole caffeate: The first molecular salt of bifonazole with enhanced biopharmaceutical property based on experiments and quantum chemistry research;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-09
2. An analysis of multidrug multicomponent crystals as tools for drug development;Journal of Controlled Release;2024-05
3. Measurement and Thermodynamic Modeling of Oxaprozin Solubility in Polymers and Mixed Solutions;Journal of Chemical & Engineering Data;2024-03-05
4. Co-crystallization: a green approach for the solubility enhancement of poorly soluble drugs;CrystEngComm;2024
5. Molecular complexes of drug combinations: A review of cocrystals, salts, coamorphous systems and amorphous solid dispersions;International Journal of Pharmaceutics;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3